These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of retroperitoneal lymph nodes in the treatment of ovarian cancer. Ushijima K Int J Clin Oncol; 2007 Jun; 12(3):181-6. PubMed ID: 17566840 [TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Spirtos NM; Gross GM; Freddo JL; Ballon SC Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667 [TBL] [Abstract][Full Text] [Related]
7. [Retroperitoneal lymph node metastasis in patients with ovarian cancer]. Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072 [TBL] [Abstract][Full Text] [Related]
8. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [TBL] [Abstract][Full Text] [Related]
9. Update on lymphadenectomy in early and advanced ovarian cancer. Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003 [TBL] [Abstract][Full Text] [Related]
10. Lymph node-positive stage IIIC ovarian cancer: a separate entity? Berek JS Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908 [TBL] [Abstract][Full Text] [Related]
11. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Yavuzcan A; Baloglu A; Cetinkaya B Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011 [TBL] [Abstract][Full Text] [Related]
12. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer]. Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137 [TBL] [Abstract][Full Text] [Related]
13. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. du Bois A; Reuss A; Harter P; Pujade-Lauraine E; Ray-Coquard I; Pfisterer J; ; J Clin Oncol; 2010 Apr; 28(10):1733-9. PubMed ID: 20194855 [TBL] [Abstract][Full Text] [Related]
14. Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. Morice P; Pautier P; Lhommé C; Castaigne D J Natl Cancer Inst; 2005 Nov; 97(21):1620-1; author reply 1621-3. PubMed ID: 16264185 [No Abstract] [Full Text] [Related]
15. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer]. Salet-Lizée D; Alsary S J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358 [TBL] [Abstract][Full Text] [Related]
16. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD; Dowdy S; Podratz KC; Cliby WA Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [TBL] [Abstract][Full Text] [Related]
17. Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. Querleu D; Ferron G J Natl Cancer Inst; 2005 Nov; 97(21):1621; author reply 1621-3. PubMed ID: 16264186 [No Abstract] [Full Text] [Related]
19. Lymphadenectomy in ovarian cancer: standard of care or unnecessary risk. Trimbos JB Curr Opin Oncol; 2011 Sep; 23(5):507-11. PubMed ID: 21602676 [TBL] [Abstract][Full Text] [Related]
20. [A rational treatment of stage I epithelial ovarian cancer]. Wang W; Huo R Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]